Newtyn Management, LLC - Q3 2017 holdings

$619 Million is the total value of Newtyn Management, LLC's 20 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 60.0% .

 Value Shares↓ Weighting
ADNT SellADIENT PLC$107,087,000
+7.4%
1,275,000
-16.4%
17.30%
+2.7%
FCEA SellFOREST CITY RLTY TR INC$66,964,000
-20.8%
2,625,000
-25.0%
10.82%
-24.3%
ATGE BuyADTALEM GLOBAL ED INC$57,360,000
+8.0%
1,600,000
+14.3%
9.27%
+3.3%
HRG SellHRG GROUP INC$51,357,000
-13.4%
3,290,000
-1.8%
8.30%
-17.2%
AABA SellALTABA INC$46,368,000
-29.1%
700,000
-41.7%
7.49%
-32.1%
EFX NewEQUIFAX INC$45,046,000425,000
+100.0%
7.28%
UHAL SellAMERCO$44,613,000
-22.4%
119,000
-24.2%
7.21%
-25.7%
TWX SellTIME WARNER INC$27,457,000
-0.6%
268,000
-2.5%
4.44%
-4.9%
SPR SellSPIRIT AEROSYSTEMS HLDGS INC$27,202,000
-40.3%
350,000
-55.5%
4.40%
-42.9%
LILAK SellLIBERTY GLOBAL PLC$25,397,000
+7.4%
1,090,000
-1.4%
4.10%
+2.7%
QCP BuyQUALITY CARE PPTYS INC$23,250,000
+41.1%
1,500,000
+66.7%
3.76%
+35.0%
LBRDA NewLIBERTY BROADBAND CORP$23,074,000245,000
+100.0%
3.73%
FRGI NewFIESTA RESTAURANT GROUP INC$19,000,0001,000,000
+100.0%
3.07%
LILA BuyLIBERTY GLOBAL PLC$13,900,000
+16.1%
585,000
+6.4%
2.25%
+11.1%
AAOI NewAPPLIED OPTOELECTRONICS INC$12,934,000200,000
+100.0%
2.09%
NODK BuyNI HLDGS INC$10,740,000
+5.4%
600,000
+5.3%
1.74%
+0.8%
TXMD  THERAPEUTICSMD INC$9,522,000
+0.4%
1,800,0000.0%1.54%
-3.9%
MACK NewMERRIMACK PHARMACEUTICALS IN$5,671,000390,000
+100.0%
0.92%
FWP NewFORWARD PHARMA A/Ssponsored adr$1,584,000268,903
+100.0%
0.26%
WMGIZ NewWRIGHT MED GROUP N Vright 03/01/2019$361,000230,000
+100.0%
0.06%
EEX ExitEMERALD EXPOSITIONS EVENTS I$0-450,000
-100.0%
-1.66%
HMHC ExitHOUGHTON MIFFLIN HARCOURT CO$0-1,436,000
-100.0%
-2.98%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2017-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
SPIRIT AEROSYSTEMS HLDGS INC33Q2 202124.0%
NI HLDGS INC27Q3 20232.9%
ADIENT PLC26Q1 202317.3%
MERRIMACK PHARMACEUTICALS IN25Q3 20235.7%
PG&E CORP24Q3 202319.2%
SPECTRUM BRANDS HLDGS INC NE21Q3 20236.7%
RAFAEL HLDGS INC18Q2 20227.4%
CUSTOMERS BANCORP INC18Q1 20233.7%
BRISTOW GROUP INC14Q3 20234.8%
APPLIED OPTOELECTRONICS INC14Q3 20212.2%

View Newtyn Management, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
Newtyn Management, LLC Q3 2017 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
PFSWEB INCFebruary 14, 20231,206,5025.3%
Garrett Motion Inc.February 14, 20221,571,4512.4%
Flexion Therapeutics IncNovember 24, 20214,400,0008.7%
FLOTEK INDUSTRIES INC/CN/February 16, 20212,789,0593.8%
Forward Pharma A/SSold outFebruary 16, 202100.0%
Pfenex Inc.October 02, 2020650,0001.9%
CymaBay Therapeutics, Inc.Sold outFebruary 14, 202000.0%
Recro Pharma, Inc.Sold outFebruary 14, 202000.0%
Stable Road Acquisition Corp.February 14, 2020700,0003.9%
CSW INDUSTRIALS, INC.February 14, 2017330,0002.1%

View Newtyn Management, LLC's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G2024-03-08
SC 13D/A2024-03-07
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G2024-02-14
SC 13G2024-02-14
SC 13G2024-02-14
SC 13G2024-02-14
SC 13D/A2024-02-13
SC 13D/A2024-01-25

View Newtyn Management, LLC's complete filings history.

Compare quarters

Export Newtyn Management, LLC's holdings